DDP

DRUG10 trials

Conditions

Breast CancerBreast Cancer ModelCervical CarcinomaDisease Free SurvivalEffects of ChemotherapyEsophageal Squamous Cell CarcinomaMetastatic Breast CancerNasopharyngeal Carcinoma

Phase 2

Endostar Combined With Intensity-modulated Radiotherapy Compare With Chemoradiation for Nasopharyngeal Carcinoma

CompletedNCT02237924

First Affiliated Hospital of Guangxi Medical UniversityNasopharyngeal Carcinoma

Start: 2014-09-30End: 2022-01-31Updated: 2022-02-14

Radiotherapy Combined With S-1/DDP for Elderly Esophageal Squamous Cell Cancer.

CompletedNCT02606916

Sun Yat-sen UniversityEsophageal Squamous Cell Carcinoma

Start: 2015-07-31End: 2020-08-31Updated: 2020-09-04

Platinum Rechallenge in Patients With Platinum-sensitive mTNBC

NCT02607215

Fudan UniversityMetastatic Breast Cancer

Start: 2015-11-30End: 2022-12-31Target: 84Updated: 2022-04-20

Endostar Combined With NVB and DDP Second-line Treatment of Advanced Esophageal Squamous Cell Carcinomas

NCT02665702

Fudan UniversityEsophageal Squamous Cell Carcinoma

Start: 2016-01-31End: 2019-09-30Target: 76Updated: 2016-01-28

Endostar Combined With Concurrent Chemoradiotherapy For Locally Advanced Cervical Carcinoma

CompletedNCT03086681

Yong Zhang,MDCervical Carcinoma

Start: 2017-04-20End: 2020-09-30Updated: 2025-07-29

Endostar Combined With IP Second-line Treatment of Advanced Esophageal Squamous Cell Carcinomas

CompletedNCT03797625

Fudan UniversityEsophageal Squamous Cell Carcinoma

Start: 2017-05-04End: 2021-12-31Updated: 2025-07-23

A Study on the Efficacy and Safety of Bevacizumab in Untreated Patients With Locally Advanced Cervical Cancer

NCT04138992

Air Force Military Medical University, ChinaDisease Free Survival

Start: 2020-08-01End: 2022-05-31Target: 150Updated: 2020-06-30

Phase 3

Endostar Combined With Concurrent Chemoradiotherapy for Locoregionally Advanced Nasopharyngeal Carcinoma

NCT02907710

First Affiliated Hospital of Guangxi Medical UniversityNasopharyngeal Carcinoma

Start: 2016-10-31End: 2019-11-30Target: 300Updated: 2016-09-20

PERS Genetic Model Assistant Decision-making System of Neoadjuvant Chemotherapy for Breast Cancer

NCT03006614

Shi YanxiaBreast Cancer, Breast Cancer Model, Effects of Chemotherapy

Start: 2016-04-30End: 2023-03-31Target: 320Updated: 2017-01-16

Unknown Phase

Assessment of Cost-effectiveness in Two Empirically-based Psychotherapies for Borderline Personality Disorder: A Randomized Controlled Trial

NCT04309045

Shalvata Mental Health CenterPlacebo, Treatment 1:Dialectical Behavior Therapy (DBT), Treatment 2:Dynamic Deconstructive Psychotherapy (DDP)

Start: 2020-04-01End: 2024-10-22Target: 60Updated: 2020-03-16

2025-10-03

Endostar combined with concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone for locoregionally advanced nasopharyngeal carcinoma (LA-NPC): A phase III, prospective, randomised-controlled, multicenter clinical trial.

Journal of Clinical Oncology2024-06-015 citations

Recombinant human endostatin combined with intensity-modulated radiotherapy in low-risk locoregionally advanced nasopharyngeal carcinoma: A phase II, randomized, multicenter clinical trial.

Journal of Clinical Oncology2022-06-012 citations

Rh-Endostatin Plus Irinotecan/Cisplatin as Second-Line Therapy for Advanced Esophageal Squamous Cell Carcinoma: An Open-Label, Phase II Study

The Oncologist2022-01-0135 citations

Endostar combined with intensity-modulated radiotherapy in low-risk local advanced nasopharyngeal carcinoma: A phase II, randomized, multicentric clinical trial.

Journal of Clinical Oncology2021-05-201 citations

A phase II randomized, multicentric clinical trail comparing recombinant human endostatin plus intensity-modulated radiotherapy versus concurrent chemoradiotherapy in locally advanced low-risk nasopharyngeal carcinoma.

Journal of Clinical Oncology2017-05-201 citations

DDP

Sponsors

Conditions

Phase 2

Phase 3

Unknown Phase

Related Papers